Richard Pzena
Pzena Investment Management
Richard Pzena Amgen Inc stake
total: 584
Pzena Investment Management AMGN trades
- Total transactions:
- 32
- New positions:
- 2
- Sold out:
- 2
- Added:
- 13
- Reduced:
- 15
- Held since:
- 2024 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2025 Q1
According to 2026 Q2 report, Richard Pzena doesn't hold any Amgen Inc (AMGN) shares. To date, the estimated cost basis is nearly $260.64 for "buy" trades and estimated average "sell" price is $260.64. Pzena Investment Management first purchased AMGN in 2016 Q3, initially acquiring 1,196 shares. Richard Pzena later completely sold out the position and invested in Amgen Inc again in 2024 Q4. Since the initial investment in Amgen Inc (AMGN), Pzena Investment Management has made 31 more transactions.
When did Richard Pzena sell Amgen Inc (AMGN)?
Richard Pzena sold off the entire Amgen Inc (AMGN) position in 2025 Q1.
When did Richard Pzena buy Amgen Inc (AMGN)?
Richard Pzena first invested in Amgen Inc (AMGN) in 2016 Q3 at the reported quarter-end price of $167.22 per share.
What's the cost basis of Pzena Investment Management's AMGN stake?
The estimated cost basis for Amgen Inc (AMGN) stake is around $260.64 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $260.64
- Weighted AVG sell price:
- $260.64
Richard Pzena's historical trades in Amgen Inc
32 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q1
|
0.00%
|
0
|
$260.64
|
|
-100% (-803)
|
-0%
|
|
2024 Q4
|
0.00%
|
803
|
$260.64
|
$209,294
|
new
|
+0%
|
|
2023 Q4
|
0.00%
|
0
|
$268.76
|
|
-100% (-235,266)
|
-0.27%
|
|
2023 Q3
|
0.27%
|
235,266
|
$268.76
|
$63,230,090
|
-53.45% (-270,087)
|
-0.31%
|
|
2023 Q2
|
0.48%
|
505,353
|
$222.02
|
$112,198,473
|
-2.30% (-11,895)
|
-0.01%
|
|
2023 Q1
|
0.54%
|
517,248
|
$241.75
|
$125,044,704
|
+1.50% (+7,622)
|
+0.01%
|
|
2022 Q4
|
0.59%
|
509,626
|
$262.64
|
$133,848,173
|
+2.02% (+10,094)
|
+0.01%
|
|
2022 Q3
|
0.56%
|
499,532
|
$225.40
|
$112,595,000
|
-4.34% (-22,641)
|
-0.02%
|
|
2022 Q2
|
0.57%
|
522,173
|
$243.30
|
$127,045,000
|
-1.89% (-10,037)
|
-0.01%
|
|
2022 Q1
|
0.49%
|
532,210
|
$241.82
|
$128,699,000
|
-0.50% (-2,660)
|
-0%
|
|
2021 Q4
|
0.45%
|
$224.97
|
+0.30% (+1,598)
|
|||
|
2021 Q3
|
0.45%
|
$212.65
|
-11.26% (-67,648)
|
|||
|
2021 Q2
|
0.57%
|
$243.75
|
+10.24% (+55,824)
|
|||
|
2021 Q1
|
0.55%
|
$248.81
|
+6.08% (+31,246)
|
|||
|
2020 Q4
|
0.56%
|
$229.92
|
+2.39% (+11,973)
|
|||
|
2020 Q3
|
0.80%
|
$254.16
|
-6.29% (-33,694)
|
|||
|
2020 Q2
|
0.82%
|
$235.86
|
-51.33% (-564,766)
|
|||
|
2020 Q1
|
1.69%
|
$202.73
|
-15.96% (-208,970)
|
|||
|
2019 Q4
|
1.47%
|
$241.07
|
+8.27% (+100,033)
|
|||
|
2019 Q3
|
1.27%
|
$193.51
|
-0.99% (-12,046)
|
|||
|
2019 Q2
|
1.19%
|
$184.28
|
+28.56% (+271,301)
|
|||
|
2019 Q1
|
0.98%
|
$189.98
|
-21.32% (-257,449)
|
|||
|
2018 Q4
|
1.37%
|
$194.67
|
-23.17% (-364,082)
|
|||
|
2018 Q3
|
1.58%
|
$207.29
|
-0.41% (-6,549)
|
|||
|
2018 Q2
|
1.46%
|
$184.59
|
+17.65% (+236,788)
|
|||
|
2018 Q1
|
1.16%
|
$170.48
|
+79,361.55% (+1,339,623)
|
|||
|
2017 Q4
|
0.00%
|
$174.17
|
+34.50% (+433)
|
|||
|
2017 Q3
|
0.00%
|
$186.45
|
-6.27% (-84)
|
|||
|
2017 Q2
|
0.00%
|
$172.52
|
+3.24% (+42)
|
|||
|
2017 Q1
|
0.00%
|
$164.23
|
-5.47% (-75)
|
|||
|
2016 Q4
|
0.00%
|
$146.50
|
+14.72% (+176)
|
|||
|
2016 Q3
|
0.00%
|
$167.22
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.